
Editor-in-Chief: Prof. Giovanni Martinotti, Università degli Studi G. D'Annunzio, Italy; University of Hertfordshire, UK.
Clinical Neuropsychopharmacology and Addiction (CNA) is a peer-reviewed, gold open-access journal committed to advancing the science and practice of neuropsychopharmacology and addiction medicine. CNA aims to publish high-quality, cutting-edge research that explores the psychopharmacological treatment of neuropsychiatric disorders, substance use disorders, and behavioral addictions, fostering innovation and interdisciplinary collaboration in these critical areas. It is published quarterly online by Scilight Press. More
Substance Use during Pregnancy: A Retrospective Multicenter Clinical Report from Four Italian Centers
Antonio Inserra, Francesco Di Carlo, Vincenzo Micale, Claudio D'Addario, Andrea Di Cesare, Roberto Mayer, Giulio Marasca, Giulia Francesconi, Rosa Volgare, Livia Miotti, Umberto Volpe, Mauro Pettorruso, Giovanni Martinotti
2026, 2(3): 13. doi: 10.53941/cna.2026.100013

Patterns of Psychedelic Use in Italy: Insights from the Global Psychedelic Survey
Matteo Buonarroti, Beatrice Dal Bianco, Alessandro Lo Jacono, Fabio Fesce, Alice Jelmoni, Lucia Cicchi, Andrea Anastasi, Eugenio Rossi, Mauro D'Alonzo, Alessandro Gelao, Caterina Bartoli, Omer Ahmed Syed, Christopher Nicholas, David Luke, Kyle Greenway, Sara Gloeckler, Sara De La Salle, Kobi Bernstein, Allison Feduccia, Alexandre Lehmann, Jacob S. Aday, Stephanie Lake, Daniel Kruger, Philippe Lucas
2026, 2(3): 12. doi: 10.53941/cna.2026.100012
The Dopaminergic Coup d’État: Neurobiology of Addiction and the Architecture of Desire
Claudia Anna Filloramo, Luigi Dattoli
2026, 2(3): 11. doi: 10.53941/cna.2026.100011
Occupational stress, Glossophobia, and Impostor Cognitions: An Integrative Clinical Case Study of Anxiety and Maladaptive Psychotropic Coping
Laila ESSFIOUI
2026, 2(2): 10. doi: 10.53941/cna.2026.100010
Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study
Giacomo d'Andrea, Luca Persico, Clara Cavallotto, Serena Panichella, Alessia Santeusanio, Alessandra Di Tullio, Michela D'Angola, Arianna Rosati, Antonio Inserra, Gianfranco Tamagnini, Cristina Di Puorto, Virginio Salvi, Beniamino Tripodi, Domenico De Berardis, Vassilis Martiadis, Milena Piccirillo, Fabiola Raffone, Tommaso Vannucchi, Andrea Barra, Matteo Lupi, Livia Miotti, Andrea Di Cesare, Mauro Pettorruso
2026, 2(2): 9. doi: 10.53941/cna.2026.100009
The Role of Probiotic Supplementation in Alcohol-Seeking Behavior: Behavioral and Neurochemical Correlates
Huma Ikram, Shahla Perveen, Darakhshan J. Haleem
2026, 2(2): 8. doi: 10.53941/cna.2026.100008

Deaths Involving Gabapentin and Pregabalin, Scotland, 2000–2024: A Descriptive Account
John Martin Corkery, Amira Guirguis, Fabrizio Schifano
2026, 2(2): 7. doi: 10.53941/cna.2026.100007
Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential
Antonio Inserra, Francesca Zoratto, Mauro Pettorruso, Giovanni Martinotti
2026, 2(2): 6. doi: 10.53941/cna.2026.100006

Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?
Alessio Mosca, Filippo Maria Ferro
2026, 2(1): 5. doi: 10.53941/cna.2026.100005
Aripiprazole Long Acting and Clozapine: Between Efficacy and Tolerability
Luca Persico, Ludovica Di Sante, Michele Xynelis, Andrea Miuli, Alessio Mosca, Mauro Pettorruso
2026, 2(1): 4. doi: 10.53941/cna.2026.100004